nonprofit logo

Melanoma Tissue Bank Consortium

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 462454076 ✦ Sacramento, CA ✦ Designated as a 501(c)(3)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is Melanoma Tissue Bank Consortium?

The Melanoma Tissue Bank Consortium (MTBC) is a collaborative initiative led by top-tier melanoma researchers. Its mission involves pooling resources from nonprofit organizations, such as AIM at Melanoma and Skin of Steel, to fund this institution. In 2022, MTBC received $250,000 in donations, with four US sites actively collecting tissue samples. Furthermore, discussions and preliminary steps were taken to establish two tissue bank sites in Australia, aiming to collect tissue there as well. The consortium operates as a "virtual" tissue bank, providing melanoma researchers with tissue samples for their institutionally reviewed projects. This process supports fundamental research in both public and private sectors, contributing significantly to the understanding and treatment of melanoma.

Is Melanoma Tissue Bank Consortium legitimate?

Melanoma Tissue Bank Consortium is a legitimate nonprofit organization registered as a 501(c)(3) entity. Melanoma Tissue Bank Consortium submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0

For more financial information, click here

What is the mission statement of Melanoma Tissue Bank Consortium?

The Melanoma Tissue Bank Consortium is a collaborative effort among top-tier melanoma research institutions. Their primary mission is to pool their tissue and data resources into a virtual bank, facilitating priority access for their institutionally approved research projects. This initiative aims to provide essential tissue samples for fundamental public and private research in the field of melanoma. In 2022, the consortium received substantial financial support, totaling $250,000, from non-profit organizations Aim at Melanoma and Skin of Steel, enabling them to collect tissue samples at their US sites. Discussions and preliminary plans were also underway to establish two new sites in Australia, further expanding their tissue collection efforts.

What is the revenue of Melanoma Tissue Bank Consortium?

Melanoma Tissue Bank Consortium's revenue in 2023 was $596,164.

Who are the executives of Melanoma Tissue Bank Consortium and what are their salaries?

Here are 3 key members and their salaries:


Samantha Guild (President)
  • Compensation: $0
  • Related: $0
  • Other: $0
Stephen A Sullivan (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Alicia Oberman (Sect/Treasurer)
  • Compensation: $0
  • Related: $0
  • Other: $0
Where can I find the form 990 for Melanoma Tissue Bank Consortium?

Melanoma Tissue Bank Consortium's most recent form 990 was submitted in 2023 and can be accessed here.

Mission Statement of Melanoma Tissue Bank Consortium

The Melanoma Tissue Bank Consortium, a collaboration of leading melanoma researchers, was established with the mission to pool their tissue and data resources into a virtual tissue bank. This consortium aims to provide melanoma tissue for fundamental public and private research projects, thereby contributing significantly to the advancement of melanoma research. In 2022, the consortium received generous donations, totaling $250,000, from non-profit organizations AIM at Melanoma and Skin of Steel. These donations have enabled the consortium to collect tissue at all four US sites, with plans to expand its operations to two sites in Australia. The Melanoma Tissue Bank Consortium is dedicated to continuing its tissue collection efforts and securing further funding to support its mission of advancing melanoma research through the provision of essential tissue samples.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

The Melanoma Tissue Bank Consortium has emerged as a vital resource for advancing melanoma research. By uniting tier-one researchers across various institutions, it facilitates the pooling of tissue samples and clinical data in a "virtual" tissue bank, significantly enhancing the quality and accessibility of research materials. Researchers engaged in institutionally approved projects receive priority access to these samples, fostering innovative studies that could lead to breakthroughs in understanding and treating melanoma.

In 2022, the Consortium made substantial progress, securing $250,000 in funding that has enabled the collection of tissue across four U.S. sites. Additionally, plans are underway to establish two new sites in Australia, further expanding the reach and impact of the Consortium. This initiative not only promotes collaboration among leading melanoma researchers but also supports fundamental research that is crucial for developing effective treatments.

Overall, the Melanoma Tissue Bank Consortium plays a critical role in accelerating the research agenda on melanoma, addressing one of the most serious forms of skin cancer, and ultimately contributing to improved patient outcomes through enhanced scientific discovery and innovation.




This information is meant to be a general summary of Melanoma Tissue Bank Consortium. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$596,164 (2023)
Expenses
$244,903 (2023)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2023.

  • Investment Income: $22,801
  • Gross Receipts: $596,164

Assets and Liabilities:

  • Total Assets: $1,369,044
  • Total Liabilities: $0
  • Net Assets: $1,369,044

Want to help this charity, for free? You can click here to learn more about Give Freely

Organization Details

Founding Year

2013

Principal Officer

Samantha Guild

NTEE Category

Code: G30 - Disease

If you are a representative of Melanoma Tissue Bank Consortium and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.